SuperSport, your undisputed World of Champions, is turning the "Month of Love" into a celebration of world-class competition, reaffirming its position as the continent’s most extensive provider of ...

This article first appeared on GuruFocus. A class action lawsuit filed on Friday is bringing Novo Nordisk (NYSE:NVO) back into the spotlight, with allegations that its handling of competition around ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

An estimated 141,984 bottles of a popular cholesterol medication have been recalled because they may not meet certain regulations. New Jersey-based Ascend Laboratories, LLC issued the recall last ...

Hims & Hers Health announced plans to expand to Canada in 2026. Hims will offer generic copies of semaglutide drugs in Canada as Novo Nordisk loses patent protection. Novo Nordisk will lose its patent ...

25/06/09 07:35:44 INFO BlockManagerInfo: Added broadcast_39_piece0 in memory on 10.51.0.162:34665 (size: 57.5 KiB, free: 992.6 MiB) 25/06/09 07:35:44 INFO BlockManagerInfo: Added broadcast_39_piece0 ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Value stream management involves people in the organization to examine workflows and other processes to ensure they are deriving the maximum value from their efforts while eliminating waste — of ...

Add Yahoo as a preferred source to see more of our stories on Google. The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could be ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.